References
1. Steinberg MH. Management of sickle cell disease. N Engl J Med 1999;340:1021-1030.
3. Bunn HF. Pathogenesis and treatment of sickle cell disease. N Engl J Med 1997;337:762-769.
4. Steinberg MH. Pathophysiology of sickle cell disease. Baillieres Clin Haematol 1998;11:163-184.
5. Ballas SK, Mohandas N. Sickle red cell microrheology and sickle blood rheology. Microcirculation 2004;11:209-225.
6. Koshy M, Weiner SJ, Miller ST, et al. Surgery and anesthesia in sickle cell disease. Cooperative Study of Sickle Cell Diseases. Blood 1995;86:3676-3684.
7. Schmalzer EA, Lee JO, Brown AK, et al. Viscosity of mixtures of sickle and normal red cells at varying hematocrit levels. Implications for transfusion Transfusion 1987;27:228-233.
8. Howard J, Malfroy M, Llewelyn C, et al. The Transfusion Alternatives Preoperatively in Sickle Cell Disease (TAPS) study: a randomised, controlled, multicentre clinical trial. Lancet 2013;381:930-938.
9. Vichinsky EP, Haberkern CM, Neumayr L, et al. A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. The Preoperative Transfusion in Sickle Cell Disease Study Group. N Engl J Med 1995;333:206-213.
10. Firth PG. Anesthesia and hemoglobinopathies. Anesthesiol Clin 2009;27:321-336.
11. Firth PG, McMillan KN, Haberkern CM, et al. A survey of perioperative management of sickle cell disease in North America. Paediatr Anaesth 2011;21:43-49.
12. De Jong A, Futier E, Millot A, et al. How to preoxygenate in operative room: healthy subjects and situations "at risk.". Ann Fr Anesth Reanim 2014;33:457-461.
13. Vichinsky EP, Neumayr LD, Earles AN, et al. Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group N Engl J Med 2000;342:1855-1865.
14. Naik RP, Streiff MB, Haywood C, Jr et al. Venous thromboembolism incidence in the Cooperative Study of Sickle Cell Disease. J Thromb Haemost 2014;12:2010-2016.
15. Stein PD, Beemath A, Meyers FA, et al. Deep venous thrombosis and pulmonary embolism in hospitalized patients with sickle cell disease. Am J Med 2006;119:897.e7-e11.
16. Novelli EM, Huynh C, Gladwin MT, et al. Pulmonary embolism in sickle cell disease: a case-control study. J Thromb Haemost 2012;10:760-766.
17. Ataga KI, Key NS. Hypercoagulability in sickle cell disease: new approaches to an old problem. Hematology Am Soc Hematol Educ Program 2007;:91-96.
18. Gould MK, Garcia DA, Wren SM, et al. Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012;141(2 Suppl):e227S-e277S.
19. Falck-Ytter Y, Francis CW, Johanson NA, et al. Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012;141(2 Suppl):e278S-e325S.